Fedarko N S, Termine J D, Young M F, Robey P G
Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1990 Jul 25;265(21):12200-9.
Osteoblasts elaborate a dynamic extracellular matrix that is constructed and mineralized as bone is formed. This matrix is primarily composed of collagen, along with noncollagenous proteins which include glycoproteins and proteoglycans. After various times in culture, human bone cells were labeled with [35S]sulfate, [3H] leucine/proline, or [3H]glucosamine and the metabolism of hyaluronan and four distinct species of proteoglycans (PGs) was assayed in the medium, cell layer, and intracellular pools. These cells produce hyaluronan (Mr approximately 1,400,000; a chondroitin sulfate PG (CSPG), Mr approximately 600,000; a heparan sulfate PG (HSPG), Mr approximately 400,000; and two dermatan sulfate PGs with Mr approximately 270,000 (biglycan, PG I) and Mr approximately 135,000 (decorin, PG II) that distribute between the medium and cell layer. Two days following subculture, 12 h [35S]sulfate steady-state labeling yielded a composition of 24, 27, 31, and 18% for total CSPG, HSPG, biglycan, and decorin, respectively. While HSPG and decorin levels and distribution between medium and cell layer remained relatively constant during steady-state labeling at different times in culture, CSPG and biglycan levels increased dramatically at late stages of growth, and their distribution changed throughout culture. These results were independent of cell density, media depletion, and labeling pool effects. In contrast, hyaluronan synthesis was uncoupled from PG synthesis and apparently density-dependent. Pulse chase labeling at different stages of culture showed that the CSPG and decorin behaved as secretory PGs. Both HSPG and biglycan underwent catabolism, with HSPG possessing a t1/2 of 8 h and biglycan a t1/2 of 4 h. While the rate of HSPG turnover did not appreciably change between early and late culture, that of biglycan decreased. The mRNA for decorin was constant, while that of biglycan changed during culture. These results suggest that each PG possesses a distinct pattern of cellular and temporal distribution that may reflect specific stages in matrix formation and maturation.
成骨细胞精心构建一种动态的细胞外基质,该基质在骨形成过程中构建并矿化。这种基质主要由胶原蛋白组成,还包括非胶原蛋白,其中有糖蛋白和蛋白聚糖。在培养不同时间后,用人骨细胞用[35S]硫酸盐、[3H]亮氨酸/脯氨酸或[3H]葡糖胺进行标记,并检测培养基、细胞层和细胞内池中的透明质酸和四种不同类型蛋白聚糖(PGs)的代谢情况。这些细胞产生透明质酸(分子量约1,400,000)、一种硫酸软骨素PG(CSPG,分子量约600,000)、一种硫酸乙酰肝素PG(HSPG,分子量约400,000)以及两种硫酸皮肤素PG,分子量分别约为270,000(双糖链蛋白聚糖,PG I)和135,000(核心蛋白聚糖,PG II),它们分布于培养基和细胞层之间。传代培养两天后,12小时的[35S]硫酸盐稳态标记结果显示,总CSPG、HSPG、双糖链蛋白聚糖和核心蛋白聚糖的组成分别为24%、27%、31%和18%。在培养不同时间的稳态标记过程中,HSPG和核心蛋白聚糖的水平及其在培养基和细胞层之间的分布保持相对恒定,而CSPG和双糖链蛋白聚糖的水平在生长后期显著增加,且其分布在整个培养过程中发生变化。这些结果与细胞密度、培养基消耗和标记池效应无关。相比之下,透明质酸的合成与PG的合成解偶联,且明显依赖于细胞密度。在培养的不同阶段进行脉冲追踪标记显示,CSPG和核心蛋白聚糖表现为分泌型PG。HSPG和双糖链蛋白聚糖都经历分解代谢,HSPG的半衰期为8小时,双糖链蛋白聚糖的半衰期为4小时。虽然HSPG的周转速率在培养早期和晚期之间没有明显变化,但双糖链蛋白聚糖的周转速率下降。核心蛋白聚糖的mRNA保持恒定,而双糖链蛋白聚糖的mRNA在培养过程中发生变化。这些结果表明,每种PG都具有独特的细胞和时间分布模式,这可能反映了基质形成和成熟的特定阶段。